[1]
“Defining and Treating Moderate Plaque Psoriasis in a Real-World Clinical Setting: A Dermatologist Survey and Prospective 6-Month Chart Review of Patients Treated with Apremilast”, J of Skin, vol. 1, no. 3.1, p. s7, Oct. 2017, doi: 10.25251/skin.1.supp.6.